Kevin W. O'Neil, MD, FACP, CMD and Chief Medical Officer of Internal Medicine and Geriatrics reviews how to navigate the intricacies of substance abuse in older adults.
Substance abuse disorders are now classified as mental disorders according to the DSM-5. Addiction changes the brain in fundamental ways and causes compulsive drug-seeking behaviors that override the ability to control impulses. Approximately 21.5 million Americans had a substance use disorder in the past year, including alcohol and illicit drugs. Co-occurring mental health and substance use disorders are common, with 7.9 million people having both in the past year. Integrated treatment that addresses both disorders together is most effective for those with co-occurring disorders.
Substance use disorders are characterized by impaired control over substance use, social impairment, risky use, and pharmacological changes. The addiction cycle involves craving, compulsion, loss of control, and continued use despite consequences, driven by the brain's reward system and neurotransmitters like dopamine and serotonin. Risk factors include psychological, behavioral, social, demographic, family, and genetic factors. Around 9.3% of Americans currently use illicit drugs, most commonly marijuana and prescription pain relievers among teenagers. Alcohol and tobacco use is declining overall but binge drinking and opioid/heroin overdoses continue to rise significantly.
This document discusses substance use disorders, specifically opioid use disorder. It defines key terms related to substance dependence and provides details on the epidemiology, etiology, mechanisms of action, comorbidities, diagnosis, and treatment of opioid use disorder. The treatment of opioid use disorder involves opioid substitution therapy, with methadone and buprenorphine being the most commonly used replacement therapies globally. The history and goals of opioid substitution therapy in Nepal are also summarized.
Elderly individuals are at risk of psychiatric problems like dementia and depression. Dementia affects 5-7% of those over 65 and 40% over 85, with Alzheimer's disease being the most common type. Depression is also common in the elderly. Treatment involves identifying the precise condition, using drugs like acetylcholinesterase inhibitors for dementia or antidepressants for depression, and providing psychosocial support. Psychiatric disorders in the elderly like schizophrenia require careful use of antipsychotic drugs and family psychoeducation.
This presentation is about geriatric Psychiatry awareness. it contains basic information about what is geriatric psychiatry, which are the main psychiatry disorder found in elderly and how to manage them?. it contains some detailed information about late life depression, delirium and dementia in geriatric population.
Substance use disorders are worldwide issues that affect people of all genders, races, and backgrounds. They are defined as a cluster of physiological and behavioral symptoms wherein substance use takes priority over other activities and responsibilities. Long term substance use can lead to both physical and psychological complications due to toxicity and dependence. Treatment involves screening, assessment, brief interventions, advice to quit, agreement to a treatment plan, pharmacotherapy tailored to the substance, and monitoring for withdrawal symptoms and continued abstinence. Non-pharmacological treatments like counseling are also important. Management at the primary care level can help address this widespread issue.
This document discusses dual diagnosis, which refers to co-occurring mental health and substance use disorders. It provides definitions of dual diagnosis from medical taxonomy and from Williams, who describes four types: primary mental illness leading to substance use; primary substance use leading to psychiatric issues; dual primary diagnoses occurring simultaneously; and common etiological factors leading to both. The document analyzes four case studies according to Williams' definitions and provides recommendations for practitioners, including engagement, assessment, avoiding assumptions, optimism, harm reduction, information sharing, and multi-agency collaboration.
Treatment resistant schizophrenia & Treatment resistant depressionEnoch R G
This document discusses treatment resistant schizophrenia and provides guidelines for its management. It defines treatment resistance and outlines criteria from Kane and others. Factors associated with poor outcomes are biological, symptomatic, environmental, illness-related and pharmacological. The neurobiology of treatment resistant schizophrenia involves dopamine, glutamate, genetics and neuroanatomy. Management guidelines are provided from NICE and involve trials of clozapine as the gold standard treatment. Clozapine details include pharmacology, dosage, side effects, monitoring and predictors of response. Studies demonstrate clozapine's superior efficacy over other antipsychotics for treatment resistant schizophrenia.
Substance abuse disorders are now classified as mental disorders according to the DSM-5. Addiction changes the brain in fundamental ways and causes compulsive drug-seeking behaviors that override the ability to control impulses. Approximately 21.5 million Americans had a substance use disorder in the past year, including alcohol and illicit drugs. Co-occurring mental health and substance use disorders are common, with 7.9 million people having both in the past year. Integrated treatment that addresses both disorders together is most effective for those with co-occurring disorders.
Substance use disorders are characterized by impaired control over substance use, social impairment, risky use, and pharmacological changes. The addiction cycle involves craving, compulsion, loss of control, and continued use despite consequences, driven by the brain's reward system and neurotransmitters like dopamine and serotonin. Risk factors include psychological, behavioral, social, demographic, family, and genetic factors. Around 9.3% of Americans currently use illicit drugs, most commonly marijuana and prescription pain relievers among teenagers. Alcohol and tobacco use is declining overall but binge drinking and opioid/heroin overdoses continue to rise significantly.
This document discusses substance use disorders, specifically opioid use disorder. It defines key terms related to substance dependence and provides details on the epidemiology, etiology, mechanisms of action, comorbidities, diagnosis, and treatment of opioid use disorder. The treatment of opioid use disorder involves opioid substitution therapy, with methadone and buprenorphine being the most commonly used replacement therapies globally. The history and goals of opioid substitution therapy in Nepal are also summarized.
Elderly individuals are at risk of psychiatric problems like dementia and depression. Dementia affects 5-7% of those over 65 and 40% over 85, with Alzheimer's disease being the most common type. Depression is also common in the elderly. Treatment involves identifying the precise condition, using drugs like acetylcholinesterase inhibitors for dementia or antidepressants for depression, and providing psychosocial support. Psychiatric disorders in the elderly like schizophrenia require careful use of antipsychotic drugs and family psychoeducation.
This presentation is about geriatric Psychiatry awareness. it contains basic information about what is geriatric psychiatry, which are the main psychiatry disorder found in elderly and how to manage them?. it contains some detailed information about late life depression, delirium and dementia in geriatric population.
Substance use disorders are worldwide issues that affect people of all genders, races, and backgrounds. They are defined as a cluster of physiological and behavioral symptoms wherein substance use takes priority over other activities and responsibilities. Long term substance use can lead to both physical and psychological complications due to toxicity and dependence. Treatment involves screening, assessment, brief interventions, advice to quit, agreement to a treatment plan, pharmacotherapy tailored to the substance, and monitoring for withdrawal symptoms and continued abstinence. Non-pharmacological treatments like counseling are also important. Management at the primary care level can help address this widespread issue.
This document discusses dual diagnosis, which refers to co-occurring mental health and substance use disorders. It provides definitions of dual diagnosis from medical taxonomy and from Williams, who describes four types: primary mental illness leading to substance use; primary substance use leading to psychiatric issues; dual primary diagnoses occurring simultaneously; and common etiological factors leading to both. The document analyzes four case studies according to Williams' definitions and provides recommendations for practitioners, including engagement, assessment, avoiding assumptions, optimism, harm reduction, information sharing, and multi-agency collaboration.
Treatment resistant schizophrenia & Treatment resistant depressionEnoch R G
This document discusses treatment resistant schizophrenia and provides guidelines for its management. It defines treatment resistance and outlines criteria from Kane and others. Factors associated with poor outcomes are biological, symptomatic, environmental, illness-related and pharmacological. The neurobiology of treatment resistant schizophrenia involves dopamine, glutamate, genetics and neuroanatomy. Management guidelines are provided from NICE and involve trials of clozapine as the gold standard treatment. Clozapine details include pharmacology, dosage, side effects, monitoring and predictors of response. Studies demonstrate clozapine's superior efficacy over other antipsychotics for treatment resistant schizophrenia.
This document discusses substance use disorders and alcohol use disorders. It defines key terms related to substance use like intoxication, addiction, tolerance, withdrawal, dependence, abuse and toxicity. It describes the various stages of alcohol use from early to middle to final stages. It discusses the epidemiology, etiology, types, effects and treatment of alcohol use disorders. Substance use disorders can be broadly categorized into substance use disorders and substance-induced disorders.
Nearly half of the world's population is affected by mental illness which impacts self-esteem, relationships and ability to function. Good mental health allows one to realize their abilities and cope with stress, while poor mental health prevents a normal life. Mental health involves well-being and functioning well, while mental illness affects thinking, feelings and behavior. Risk factors for mental disorders include genetics, age, toxins, infections, and family/social problems. Both physical and mental health problems interact and influence each other. Prevention strategies target promotion, early intervention, treatment and social support/rehabilitation.
This document discusses alcohol use disorders and their management. It begins by defining alcohol and its mechanisms of action in the body. It then discusses various alcohol-related terminologies and the epidemiology of alcohol use disorders. It describes the signs and symptoms of acute intoxication and withdrawal syndromes. Finally, it outlines the general principles for managing alcohol dependence, including detoxification and treatment of complications.
This document provides information on substance-related disorders including substance abuse, dependence, withdrawal, and intoxication. It defines substance abuse and dependence based on DSM-IV criteria. It describes the epidemiology, categories, and effects of commonly abused substances like stimulants, depressants, opiates, hallucinogens, inhalants, and caffeine. For each substance or class, it summarizes intoxication, withdrawal, treatment approaches, and diagnostic evaluation.
A DSM 5 Update: Substance - Related And Addictive DisordersChat 2 Recovery
Within the next year, most insurance providers will be expecting all claims to include the new DSM-5 nomenclature. It is imperative for all mental health professionals to be comfortable with the new diagnostic criteria and recording procedures. This presentation provides participants with a clear understanding of the revisions made in the category of Substance - Related and Addictive Disorders from the DSM-IV to the DSM-5.
Topics presented by Nick Lessa, CEO of Inter-Care: an addiction treatment program in New York City.
Includes:
Changes in the diagnostic criteria from the DSM–IV to the DSM-5
The distinction between Substance Use Disorders and the Substance - Induced Disorders
Recording procedures for Substance Related Disorders
This document discusses opioid dependence and addiction. It begins with an overview of opioids and their mechanism of action in the body. It then defines addiction, dependence, and tolerance. The mechanisms of dependence and addiction involve both negative reinforcement from withdrawal and positive reinforcement from rewarding effects. Physical dependence theory and positive incentive theory are described as models of addiction. The document outlines treatment options including drug substitution therapy with methadone or buprenorphine, abstinence-based treatment, and psychosocial treatments. It discusses opioid withdrawal and post-acute withdrawal syndrome. The six stages of recovery are defined. Special considerations for treating opioid addicts are noted.
Psychoeducation is the education of individuals regarding psychological or physical conditions that cause stress. It aims to improve understanding and management of the condition. Psychoeducation can be delivered in individual, family, group or social settings. It covers topics like the diagnosis, treatment, stigma reduction, lifestyle management and building self-efficacy. Research shows psychoeducation reduces relapse rates and hospitalizations for conditions like bipolar disorder when added to standard treatment. It is an effective support intervention for conditions affecting mental health and quality of life.
Non-pharmacological management of dementiaRavi Soni
This document discusses non-pharmacological methods for managing dementia, including behavioral symptoms. It begins by defining behavioral and psychological symptoms of dementia (BPSD) and noting that 90% of dementia patients experience BPSD severe enough to be problematic. Common symptoms include agitation, wandering, depression, and psychosis. The document then discusses several non-pharmacological therapies for managing BPSD, including reminiscence therapy, validation therapy, reality orientation, behavioral therapies, and sensory stimulation techniques like light therapy, acupuncture, and aromatherapy. It provides some evidence for the effectiveness of these approaches, though notes most studies have small sample sizes and more research is still needed.
This document provides an overview of substance abuse and dependence. It defines key terms like tolerance, dependence, addiction, withdrawal, and craving. It then examines specific substances in more detail, including the effects of nicotine, cannabis, opioids, alcohol, hallucinogens, cocaine, benzodiazepines, and others. For each substance, it discusses acute and long term effects, intoxication, withdrawal symptoms, hazards, and psychiatric disorders associated with abuse. The document concludes with sections on management of substance abuse/dependence, rehabilitation centers, and pharmacological treatment options.
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
Part of the Addiction Counselor Certification Training Series. Theories of addiction including moral, medical
This document provides information on geriatric psychiatry and aging-related mental health issues. It discusses several key topics:
1. Age-related changes in physiological functioning can increase vulnerability over time. Late adulthood begins around age 65 and is characterized by gradual decline in functioning of body systems.
2. Life expectancy has been increasing in India and globally, leading to growth in the elderly population. Common concerns for elderly include retirement, economic insecurity, declining health, and loss of independence.
3. Major mental health disorders in elderly include depression, delirium, and dementia. Late-life depression can present differently than depression in younger populations. Delirium is an acute change in mental status that commonly affects hospital
The document provides guidelines for assessing and evaluating disabilities in India. It describes the following:
1. Authorities in India that are responsible for providing disability certificates according to the Persons with Disabilities Act of 1995.
2. The Indian Disability Evaluation and Assessment Scale (IDEAS) which was developed to measure and quantify disability in mental disorders.
3. How the IDEAS evaluates four areas - self-care, interpersonal activities, communication and understanding, and work - to determine the level of global disability on a scale from 0-100%.
This document discusses opioid use disorder and its effects. It notes that opioids like opium, heroin, and morphine are highly addictive substances. Long term opioid use can lead to dependence and addiction through binding to mu opioid receptors in the brain. Withdrawal symptoms include flu-like symptoms like nausea and craving for the drug. Diagnosis involves examining pupils, testing urine for opioids, and observing for withdrawal symptoms. Treatment involves medication-assisted therapy with drugs like methadone or buprenorphine, counseling, and psychosocial support to prevent relapse.
This document discusses alcohol use, dependence, and treatment. It begins with an overview of the pharmacokinetics of alcohol and its effects on different body systems. Alcohol dependence is characterized by craving, loss of control, tolerance, and withdrawal symptoms. Treatment involves detoxification, counseling, mutual support groups, and pharmacotherapy using benzodiazepines, acamprosate, naltrexone, disulfiram, and other medications. The combination of pharmacological and psychosocial therapies provides the most effective management of alcohol dependence.
Drug addiction is a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.
Brain changes that occur over time with drug use challenge an addicted person’s self-control and interfere with their ability to resist intense urges to take drugs. This is why drug addiction is also a relapsing disease.
Relapse is the return to drug use after an attempt to stop. Relapse indicates the need for more or different treatment.
Most drugs affect the brain's reward circuit by flooding it with the chemical messenger dopamine. This overstimulation of the reward circuit causes the intensely pleasurable "high" that leads people to take a drug again and again.
This document discusses alcohol use disorders and their treatment. It defines key terms like acute intoxication, withdrawal state, and dependence syndrome. It describes the major symptoms of alcohol withdrawal. It also outlines chronic health complications of alcohol use like Wernicke's encephalopathy and Korsakoff's psychosis. The document lists screening tools and treatments for alcohol dependence, including detoxification with benzodiazepines, vitamin supplementation, and approaches like psychotherapy, group therapy, and medications to reduce cravings or deter drinking.
This document discusses addiction, primarily focusing on alcohol and drug addiction. It defines addiction and describes the conditions of alcoholism. It provides statistics on drinking patterns in the US and details that over 60% of Americans drink, 25% sometimes drink too much, and alcohol abuse is more common among young people and whites. The document also covers the health, social, and economic costs of addiction. Physical health consequences include liver disease and early death, while social consequences include increased risk of injuries, violence and criminal behavior when intoxicated.
This document provides an introduction to addiction as a brain disease. It begins by defining substance use disorders and reviewing DSM-IV criteria for substance abuse and dependence. Epidemiological data on the prevalence of alcohol and drug use in the United States is presented. The neurobiology of addiction and how chronic drug use affects the brain is explained using imaging studies. The document concludes by discussing how physicians can intervene to treat addiction using screening, brief intervention, and referral to treatment methods.
This document discusses substance use disorders and alcohol use disorders. It defines key terms related to substance use like intoxication, addiction, tolerance, withdrawal, dependence, abuse and toxicity. It describes the various stages of alcohol use from early to middle to final stages. It discusses the epidemiology, etiology, types, effects and treatment of alcohol use disorders. Substance use disorders can be broadly categorized into substance use disorders and substance-induced disorders.
Nearly half of the world's population is affected by mental illness which impacts self-esteem, relationships and ability to function. Good mental health allows one to realize their abilities and cope with stress, while poor mental health prevents a normal life. Mental health involves well-being and functioning well, while mental illness affects thinking, feelings and behavior. Risk factors for mental disorders include genetics, age, toxins, infections, and family/social problems. Both physical and mental health problems interact and influence each other. Prevention strategies target promotion, early intervention, treatment and social support/rehabilitation.
This document discusses alcohol use disorders and their management. It begins by defining alcohol and its mechanisms of action in the body. It then discusses various alcohol-related terminologies and the epidemiology of alcohol use disorders. It describes the signs and symptoms of acute intoxication and withdrawal syndromes. Finally, it outlines the general principles for managing alcohol dependence, including detoxification and treatment of complications.
This document provides information on substance-related disorders including substance abuse, dependence, withdrawal, and intoxication. It defines substance abuse and dependence based on DSM-IV criteria. It describes the epidemiology, categories, and effects of commonly abused substances like stimulants, depressants, opiates, hallucinogens, inhalants, and caffeine. For each substance or class, it summarizes intoxication, withdrawal, treatment approaches, and diagnostic evaluation.
A DSM 5 Update: Substance - Related And Addictive DisordersChat 2 Recovery
Within the next year, most insurance providers will be expecting all claims to include the new DSM-5 nomenclature. It is imperative for all mental health professionals to be comfortable with the new diagnostic criteria and recording procedures. This presentation provides participants with a clear understanding of the revisions made in the category of Substance - Related and Addictive Disorders from the DSM-IV to the DSM-5.
Topics presented by Nick Lessa, CEO of Inter-Care: an addiction treatment program in New York City.
Includes:
Changes in the diagnostic criteria from the DSM–IV to the DSM-5
The distinction between Substance Use Disorders and the Substance - Induced Disorders
Recording procedures for Substance Related Disorders
This document discusses opioid dependence and addiction. It begins with an overview of opioids and their mechanism of action in the body. It then defines addiction, dependence, and tolerance. The mechanisms of dependence and addiction involve both negative reinforcement from withdrawal and positive reinforcement from rewarding effects. Physical dependence theory and positive incentive theory are described as models of addiction. The document outlines treatment options including drug substitution therapy with methadone or buprenorphine, abstinence-based treatment, and psychosocial treatments. It discusses opioid withdrawal and post-acute withdrawal syndrome. The six stages of recovery are defined. Special considerations for treating opioid addicts are noted.
Psychoeducation is the education of individuals regarding psychological or physical conditions that cause stress. It aims to improve understanding and management of the condition. Psychoeducation can be delivered in individual, family, group or social settings. It covers topics like the diagnosis, treatment, stigma reduction, lifestyle management and building self-efficacy. Research shows psychoeducation reduces relapse rates and hospitalizations for conditions like bipolar disorder when added to standard treatment. It is an effective support intervention for conditions affecting mental health and quality of life.
Non-pharmacological management of dementiaRavi Soni
This document discusses non-pharmacological methods for managing dementia, including behavioral symptoms. It begins by defining behavioral and psychological symptoms of dementia (BPSD) and noting that 90% of dementia patients experience BPSD severe enough to be problematic. Common symptoms include agitation, wandering, depression, and psychosis. The document then discusses several non-pharmacological therapies for managing BPSD, including reminiscence therapy, validation therapy, reality orientation, behavioral therapies, and sensory stimulation techniques like light therapy, acupuncture, and aromatherapy. It provides some evidence for the effectiveness of these approaches, though notes most studies have small sample sizes and more research is still needed.
This document provides an overview of substance abuse and dependence. It defines key terms like tolerance, dependence, addiction, withdrawal, and craving. It then examines specific substances in more detail, including the effects of nicotine, cannabis, opioids, alcohol, hallucinogens, cocaine, benzodiazepines, and others. For each substance, it discusses acute and long term effects, intoxication, withdrawal symptoms, hazards, and psychiatric disorders associated with abuse. The document concludes with sections on management of substance abuse/dependence, rehabilitation centers, and pharmacological treatment options.
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
Part of the Addiction Counselor Certification Training Series. Theories of addiction including moral, medical
This document provides information on geriatric psychiatry and aging-related mental health issues. It discusses several key topics:
1. Age-related changes in physiological functioning can increase vulnerability over time. Late adulthood begins around age 65 and is characterized by gradual decline in functioning of body systems.
2. Life expectancy has been increasing in India and globally, leading to growth in the elderly population. Common concerns for elderly include retirement, economic insecurity, declining health, and loss of independence.
3. Major mental health disorders in elderly include depression, delirium, and dementia. Late-life depression can present differently than depression in younger populations. Delirium is an acute change in mental status that commonly affects hospital
The document provides guidelines for assessing and evaluating disabilities in India. It describes the following:
1. Authorities in India that are responsible for providing disability certificates according to the Persons with Disabilities Act of 1995.
2. The Indian Disability Evaluation and Assessment Scale (IDEAS) which was developed to measure and quantify disability in mental disorders.
3. How the IDEAS evaluates four areas - self-care, interpersonal activities, communication and understanding, and work - to determine the level of global disability on a scale from 0-100%.
This document discusses opioid use disorder and its effects. It notes that opioids like opium, heroin, and morphine are highly addictive substances. Long term opioid use can lead to dependence and addiction through binding to mu opioid receptors in the brain. Withdrawal symptoms include flu-like symptoms like nausea and craving for the drug. Diagnosis involves examining pupils, testing urine for opioids, and observing for withdrawal symptoms. Treatment involves medication-assisted therapy with drugs like methadone or buprenorphine, counseling, and psychosocial support to prevent relapse.
This document discusses alcohol use, dependence, and treatment. It begins with an overview of the pharmacokinetics of alcohol and its effects on different body systems. Alcohol dependence is characterized by craving, loss of control, tolerance, and withdrawal symptoms. Treatment involves detoxification, counseling, mutual support groups, and pharmacotherapy using benzodiazepines, acamprosate, naltrexone, disulfiram, and other medications. The combination of pharmacological and psychosocial therapies provides the most effective management of alcohol dependence.
Drug addiction is a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.
Brain changes that occur over time with drug use challenge an addicted person’s self-control and interfere with their ability to resist intense urges to take drugs. This is why drug addiction is also a relapsing disease.
Relapse is the return to drug use after an attempt to stop. Relapse indicates the need for more or different treatment.
Most drugs affect the brain's reward circuit by flooding it with the chemical messenger dopamine. This overstimulation of the reward circuit causes the intensely pleasurable "high" that leads people to take a drug again and again.
This document discusses alcohol use disorders and their treatment. It defines key terms like acute intoxication, withdrawal state, and dependence syndrome. It describes the major symptoms of alcohol withdrawal. It also outlines chronic health complications of alcohol use like Wernicke's encephalopathy and Korsakoff's psychosis. The document lists screening tools and treatments for alcohol dependence, including detoxification with benzodiazepines, vitamin supplementation, and approaches like psychotherapy, group therapy, and medications to reduce cravings or deter drinking.
This document discusses addiction, primarily focusing on alcohol and drug addiction. It defines addiction and describes the conditions of alcoholism. It provides statistics on drinking patterns in the US and details that over 60% of Americans drink, 25% sometimes drink too much, and alcohol abuse is more common among young people and whites. The document also covers the health, social, and economic costs of addiction. Physical health consequences include liver disease and early death, while social consequences include increased risk of injuries, violence and criminal behavior when intoxicated.
This document provides an introduction to addiction as a brain disease. It begins by defining substance use disorders and reviewing DSM-IV criteria for substance abuse and dependence. Epidemiological data on the prevalence of alcohol and drug use in the United States is presented. The neurobiology of addiction and how chronic drug use affects the brain is explained using imaging studies. The document concludes by discussing how physicians can intervene to treat addiction using screening, brief intervention, and referral to treatment methods.
This document discusses reasons for drug use and addiction. It provides 10 reasons why drug use is more serious today, including increased potency of drugs, younger age of experimentation, and greater availability of information. It then covers basic reasons people use drugs, the nature and costs of addiction, and risk factors. Biological and psychological explanations for drug use are presented, including the role of genetics and drugs activating the brain's reward system. Finally, signs of drug abuse and risks of different drug choices are outlined.
Substance abuse and addiction during adulthoodLydia Betsy
Definition of substance abuse, addiction and adulthood. Various stages of addiction, how one can overcome addiction and substance abuse, substance abuse and addiction across adulthood years. Effect on the mental health of an individual support with research studies.
Training innovations dual diagnosis cambian fountains march 16Patrick Doyle
Dual Diagnosis describes the co-occurring problems of mental illness and substance misuse. However, the term 'dual' is something of a misnomer - the needs of this client group are often highly complex and extend beyond the relatively simplistic scenario implied by the term 'dual diagnosis'. This course uses realistic scenarios to enable participants to look at the reasons why mentally ill clients are so prone to drug and alcohol problems, the potential consequences of dual diagnosis, and current assessment and treatment approaches
Duration: half-day. one day, or two day options
Experience: None required
This course is suitable for: all staff currently working within health and social care settings in the United Kingdom. The course is designed to meet the training needs of domiciliary care agencies, care home or hospital settings and all staff. The course is also ideal for carers.
Number of Trainees: 15 maximum
Course Standard: Certificate of attendance
Equipment Needed: Hand-outs will be provided
Candidates will cover:
•Definitions of dual diagnosis and co-morbidity.
•Possible reasons for substance misuse in those with mental health difficulties
•Effects of substance misuse on those with mental health difficulties
By the end of the course Candidates will be able to:
•Discuss the relationship between substance misuse and mental health problems
•Describe the risk factors associated with these behaviours
•Understand the skills that are necessary to effectively work with clients who have dual diagnosis
This document provides an overview of health topics related to adolescence and young adulthood. It discusses the development of the adolescent brain and importance of screening and prevention during this period. Specific conditions like ADHD, substance abuse, and transitioning young adults with chronic illness are examined. The biology of adolescent development, screening recommendations, vaccinations, characteristics and treatment of ADHD, substance use trends like alcohol, tobacco, marijuana, and emerging drugs are outlined. Challenges in transitioning young adults with chronic medical conditions to adult care are also reviewed.
Alcoholism is defined as harmful and uncontrollable alcohol consumption that can cause disorders like depression and anxiety. Long-term alcoholism affects the body's metabolism, organs, and nutrition levels. It has genetic and environmental causes, and is more common in males. Symptoms include intoxication, withdrawal, tolerance, and medical conditions. Treatment aims to promote abstinence through detoxification, counseling, social support, and medications like disulfiram or naltrexone.
1) Mental illness is a widespread problem affecting approximately 10% of the population globally. It includes a wide spectrum of disorders from minor neuroses to major psychoses like schizophrenia.
2) Mental illness has multifactorial causes including genetic, organic, psychosocial, and environmental factors. Early diagnosis and treatment as well as rehabilitation services are important for management.
3) Substance abuse disorders like alcohol and drug dependence present a major public health challenge. Prevention through education, legislation, and community programs as well as treatment involving detoxification and rehabilitation are essential strategies to address this problem.
1. The document discusses various tools used to assess substance abuse, including alcohol and drug abuse. It describes screening tests like the Alcohol Use Disorders Identification Test (AUDIT), CAGE questionnaire, and Paddington Alcohol Test (PAT) which can be used to identify problematic use.
2. Assessment involves collecting both subjective and objective information through methods like screening, interviews, and testing to determine a diagnosis and treatment plan. It examines domains like medical/psychiatric history, readiness to change, and social support systems.
3. Dependence is characterized by tolerance, withdrawal symptoms, inability to cut down on use despite problems, and continuing use despite negative consequences as outlined in the DSM-IV. Tests
objectives are understanding the scop of substance abuse in the elderly and realize the future implications of substance abuse in the baby bommer cohorot and understanding the definition of alcohol dependance and how to recognize them and much more
welcome to :
http://www.ethanolabuse.com
This document discusses adolescent substance abuse, including:
- Common drugs of abuse such as alcohol, marijuana, and tobacco and emerging trends like bath salts and e-cigarettes.
- How the adolescent brain is still developing which can increase risk-taking behaviors and substance abuse.
- The co-morbidity of substance abuse with mental health conditions like depression and anxiety.
- Prevention strategies are needed to address the myths surrounding substance use and the health risks to adolescents.
This document discusses the growing problem of prescription drug abuse among teens and young adults. It notes that teens say prescription drugs are easy to get, legal, and not considered addictive. It explores where teens are getting the drugs, like from family medicine cabinets, and why they use them, such as for depression, anxiety, or fitting in. The document outlines several prescription and over-the-counter drugs that are commonly abused, like DXM in cough syrup, and notes the health risks of prolonged drug use and addiction. It also discusses warning signs of drug abuse and provides resources for parents on prevention.
This document provides an overview of addiction and substance use. It defines addiction as a chronic disease involving brain circuits, genetics, environment and life experiences. It discusses types of addiction including substance and behavioral addiction. Common addictions include tobacco, alcohol, drugs, gambling, food, video games and internet. The document reviews prevalence data on addiction from various sources. It also discusses treatment approaches for behavioral and substance use disorders including detox, individual therapy, group therapy and rehabilitation programs. Recent studies on substance use during the COVID-19 pandemic are also summarized.
OCD and Substance Use Disorder IOCDF Conference 2020StaceyConroy3
The document discusses obsessive compulsive disorder (OCD) and substance use disorders (SUD). Around 25% of people with OCD also have a co-occurring SUD. Effective treatment of OCD and SUD requires concurrent, integrated treatment that addresses both disorders. Cognitive behavioral therapy, twelve step programs, and medication can all be part of an effective treatment plan for individuals with OCD-SUD. Assessment for SUD should be included when treating OCD patients to identify potential co-occurrence and need for integrated treatment.
This document provides an introduction to a class on drugs and society. It begins with polling students to gauge their expectations and reasons for taking the class. It then outlines class policies, assignments, and expectations. The document discusses key concepts around drug use including what constitutes a drug, commonly abused drugs, and factors that influence drug use. Statistics on drug use in the United States are presented, showing high rates of alcohol, tobacco, and marijuana use. Four types of drug use and dimensions of drug abuse are defined.
The document describes an upcoming conference on addiction in the pharmacy profession from April 2-4, 2013 at the Omni Orlando Resort. The conference aims to help pharmacy professionals identify risk factors for addiction, recognize signs and symptoms of addiction, and describe resources available for those struggling with addiction. It also outlines the structure of monitoring and accountability provided by the Pharmacist Recovery Network for those in recovery. The presentation will be given by Brian Fingerson, president of the Kentucky Professionals Recovery Network, and will include a self-assessment quiz and discussion of why learning about addiction is important for pharmacy professionals.
JUVENILE
DELINQUENCY
THE CORE 5E
Chapter 10:
Drug Use and
Delinquency
Marijuana and Hashish
Marijuana
Produced from the leaves of cannabis
sativa
Hashish
Concentrated form of cannabis made of
unadulterated resin from the female plant
Main ingredient in both is tetrahydrocannabinol
(THC)
A mild hallucinogen
Most commonly used drug by teenagers
Large amounts causes distortions that produce
hallucinatory effects
Not physically addictive, but long term effects debatable
Cocaine, Crack & Heroin
Cocaine
Alkaloid derivative of the coca plant
Most powerful natural stimulant that produces euphoria, restlessness,
and excitement
It can be sniffed, snorted, or injected
Immediate feeling or rush is short lived
Crack
Processed street cocaine
Gained popularity in the mid-1980s
Relatively inexpensive
Can provide a powerful high and is highly addictive
Heroin
Most dangerous commonly abused drug
Alcohol
Drug of choice for most teenagers
64% of high school seniors reported abusing it in the past
year
70% say they have tried it
By the 12th grade, 51% reported having been drunk
Negatively impacts society
Factor in nearly half of all murders, suicides, and
accidental deaths
1.4 million drivers are arrested each year for D.U.I.
840,000 more are arrested for alcohol-related offenses
The economic cost is staggering: $185 billion lost lost
each year
Impact on Health
Long term use is linked to depression and physical
ailments, ranging from heart disease to cirrhosis of the
liver
Perceived Benefits
Reduces tension, enhances pleasure, improves social
skills, and some claim it transforms experiences for the
better
Other Drugs
Anesthetic Drugs
Central nervous system depressants
Most widely abused is phencyclidine (PCP), aka angel dust
Inhalants
Some youths inhale vapors that cause a euphoric feeling that is
followed by disorientation, slurred speech, and drowsiness
Sedatives and barbiturates
Depress the central nervous system, creating a sleeplike condition
Tranquillizers
Reduce anxiety and promote relaxation
Overuse can lead to addiction, and withdrawal can be painful and
hazardous
Other Drugs
• Hallucinogens
• Provide vivid distortions of the senses without greatly
disturbing the viewers consciousness
• Examples of common hallucinogens:
• Mescaline
• LSD
• Stimulants
• Synthetic drugs that increase blood pressure, breathing rate,
bodily activity, and elevate mood
• Methedrine is the most widely used dangerous amphetamine
• aka “meth”, “speed”, “crystal meth”
• Economic cost of meth use in the U.S. exceeds $23
billion a year
Other Drugs
Steroids
Anabolic steroids are used to gain muscle bulk and strength
Black market sales approach $1 billion annually
Cause health problems such as liver ailments, tumors, kidney
problems, sexual dysfunc ...
This document discusses mental health and substance abuse. It defines mental health as achieving a balance between one's drives and defines characteristics of mentally healthy people. It describes the prevalence of mental illness worldwide and lists common types like schizophrenia and neuroses. The causes of mental illness include organic, hereditary, social and environmental factors. The document outlines prevention, treatment and services for mental health as well as programs for substance abuse issues like alcohol and drug dependence. It provides information on commonly abused drugs and their effects while also discussing prevention and rehabilitation approaches.
This document discusses the importance of communication skills when discussing end-of-life care and advance directives. It emphasizes exploring patients' feelings, establishing trust, and focusing on hope. Key elements include acknowledging emotions, legitimizing concerns, and offering support. Discussions should explore uncertainty and include treatments' burdens and benefits to help evaluate options. The most important part of communicating advance directives is developing trust through active listening and understanding each patient's unique situation and perspective.
Learn the body’s hydration needs specific to the older adul, the signs or symptoms of dehydration, the three consequences of dehydration in the older adult and the
strategies for maintaining hydration status and/or preventing dehydration in the older adult.
H:F Festival Presentation - Ryan Wilson- CGOBrookdale
Ryan Wilson, Chief Growth Officer of Brookdale, discusses senior living and the company. Brookdale is the largest senior living provider in the US, with over 1,000 communities across 46 states serving over 102,000 residents. It has the most diversified service continuum and broad geographic footprint, with two-thirds of the US senior population living within 10 miles of a Brookdale community. Brookdale focuses on operational effectiveness, associate engagement, and customer experience to continue providing quality senior living services to a growing senior demographic.
Transportation services in senior living communities require scheduling in advance, have limited availability and are often confined to a geographic radius as they try to balance the preferences and needs of many residents all at once.
That’s why Brookdale partnered with the on-demand ridesharing service Lyft. They help us bridge this gap. Lyft’s Concierge platform allows Brookdale associates to schedule rides on behalf of residents, without the resident using a smartphone or entering credit card information.
Cross Train Your Brain - Brookdale Senior Living CEU Professional DevelopmentBrookdale
At Brookdale, we're proud to provide healthcare professionals an opportunity each month to earn Continuing Education Credits (CEU). In a CEU webinar earlier this year, Carol Cummings, RN, BSN, the Sr. Director of Optimum Life Engagement, reviewed the top ways seniors can improve overall brain health. View her presentation here for a peek into the program
Often when people hear the word sustainability they naturally think about the physical environment. For Brookdale, sustainability means that and much more. It means caring about the larger environmental and social impacts of our operations. This commitment to sustainability matters to us, to our associates and most importantly, to our residents and their loved ones. This approach to sustainability reflects one of Brookdale’s core values – we care. We encourage you to review the Brookdale 2017 Sustainability Report below for specific examples of these efforts over the past year.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Get Covid Testing at Fit to Fly PCR TestNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.
2024 HIPAA Compliance Training Guide to the Compliance OfficersConference Panel
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
MYASTHENIA GRAVIS POWER POINT PRESENTATIONblessyjannu21
Myasthenia gravis is a neurological disease. It affects the grave muscles in our body. Myasthenia gravis affects how the nerves communicate with the muscles. Drooping eyelids and/or double vision are often the first noticeable sign. It is involving the muscles controlling the eyes movement, facial expression, chewing and swallowing. It also effects the muscles neck and lip movement and respiration.
It is a neuromuscular disease characterized by abnormal weakness of voluntary muscles that improved with rest and the administration of anti-cholinesterase drugs.
The person may find difficult to stand, lift objects and speak or swallow. Medications and surgery can help the patient to relieve the symptoms of this lifelong illness.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
CANSA support - Caring for Cancer Patients' Caregivers
Substance Abuse in Older Adults
1. Substance Abuse in
Older Adults
Kevin W. O’Neil MD, FACP, CMD
Internal Medicine and Geriatrics
Chief Medical Officer
2. Objectives
• Define the prevalence of alcohol and substance abuse
among older adults.
• Name two screening instruments for alcohol abuse in
older adults and one screening instrument for
prescription drug abuse.
• Name three recommendations of an expert panel of
SAMHSA (Substance Abuse and Mental Health Services
Administration) for treatment of substance abuse.
3. • Overall prevalence in older adults about 17%
• Reasons underreported:
– Symptoms mistaken for dementia, depression, etc.
– Older adults tend to hide substance abuse
– Relatives may be ashamed and hide it
Prevalence of Alcohol and Substance Abuse
4. • One drink =
– 12 oz. beer
– 4-6 oz. glass of wine
– 1 ½ oz. distilled spirit
• Heavy use:
– Men >2/day
– Women >1/day
Alcohol Use
6. • 2.5 million older adults
• 21% of hospitalized adults over age 40
• Community Elderly
– Heavy Alcohol Use: 3-25%
– Alcohol Abuse: 2-9.6%
• Primary Care Outpatients
– 12% women
– 15% men
Prevalence of Alcohol Abuse (NIAAA)
7. • Early Onset
– Continuing
– 2/3 of older adults with alcohol abuse
• Late Onset
– Mostly previous users
– Increased use
– Or more vulnerable to EtOH effects
Onset
8. • People 65 and older consume more prescribed and
OTC medications than an other age group.
• Illicit drug problems rare in those not previously
addicts or alcoholics..
• Opiates: Abuse or dependence rare unless a history
of addiction.
• Approximate 4 addicted out of about 12,000
morphine prescriptions.
Drugs
9.
10. • Chronic use: 1.8%
• Women > Men
• 17-23% of all prescriptions for older adults
• Chronic use >4 months not recommended
• Treatment of insomnia should be limited to 7 to 10 days
with frequent monitoring and reevaluation if the
prescribed drug will be used for more than 2 to 3
weeks. Intermittent dosing at the smallest possible
dose is preferred, and no more than a 30-day supply of
hypnotics should be prescribed.
Benzodiazepines Hypnotics
11. • Legal: not driving
• Marital: widowed
• Occupational: retired
• Tolerance and Withdrawal differ
Consequences of Substance Abuse
13. • Drowsiness
• Delirium
• Forgetfulness
• Dependence and withdrawal
• 23% of adverse drug events in nursing homes
Adverse Effects
14. • Past history of alcohol use disorder (AUD)
• Male gender (2x female)
– 10% have history of AUD
– 43% of LTC veterans have history of AUD
• Loss of spouse
• Other losses
– Health, sensory, function, mobility
• Psychiatric disorder
• Nicotine, or other drug use disorder
Alcohol Use: Risk Factors
17. • Patient feels threatened
• Assure confidentiality
• Use non-judgmental approach
• Don’t rush
• A medical approach is better: “The alcohol is
affecting your liver enzymes.”
• Build on problems and causal link with alcohol/drug
use
• You and the patient against their problems
Approach To Patient
18. • Talk to others to confirm story
– Spouse
– Other family
– Friends
• Obtain permission!
Collateral Information
19. • Alcohol
– CAGE
– MAST
– AUDIT
– Maximum in last year
• Other drugs
– Use despite consequences
Screening
20. • C: Have you ever felt the need to Cut Down?
• A: Have you ever been Annoyed at criticism of your
drinking?
• G: Have you ever felt Guilty about your drinking?
• E: Have you ever had a morning Eye-opener to get
going?
CAGE
21. 21
• Simple, self-scoring test
• Twenty-two questions
• Yes or No Answers
• Scoring:
• 0-2: No apparent problem
• 3-5: Early or middle problem drinker
• 6 or more: Problem drinker
MAST: Michigan Alcoholism Screening Test
22. AUDIT: Alcohol Use Disorders Identification Test
• Developed by the World Health Organization
• Clinician-administered and self-report version
• Ten questions
• First three questions deal with quantity and
frequency of use
• Geriatric primary care out-patients
• CAGE: 5% prevalence
• AUDIT: 18% prevalence
23. • Eight item questionnaire
• Obtains information from patients about lifetime use of
substances
• Current substances use associated problems over the last 3
months (tobacco products, alcohol, cannabis, cocaine,
amphetamine-type stimulants, sedatives, sleeping pills,
hallucinogens, inhalants, opioids, ‘other’ drugs)
• Can identify a range of problems associated with substance use:
– acute intoxication
– regular use
– dependent or ‘high risk’ use
– injecting behavior.
ASSIST: Alcohol, Smoking, and Substance Involvement
Screening Test
24. • Evidence-based practice used to identify, reduce,
and prevent problematic use, abuse, and
dependence on alcohol and illicit drugs.
• SBIRT model was incited by an Institute of Medicine
recommendation that called for community-based
screening for health risk behaviors, including
substance use.
SBIRT: Screening, Brief Intervention, and Referral to
Treatment
http://www.integration.samhsa.gov/clinical-practice/sbirt
26. • Feedback on alcohol/drug use and consequences
• Reasons for use
• Reasons to cut down/stop
– Health
– Mental capacity
– Independence
• Goals, written agreement
Brief Intervention
27. • Readiness for Change (Prochaska)
– Pre-Contemplation
– Contemplation
– Preparation
– Action
• Need to believe the benefits of change
Motivational Counseling
28. • Age-specific treatment and pace
• Focus on:
– Depression, losses
– Restoration of self-esteem and social supports
• Staff experienced with elders
• Links with services for elders
Treatment
29. “ Alone we can do so little;
together we can do so much.”
— Helen Keller
29
Editor's Notes
GRAPHICS NOTE: Title font should be Georgia 37 point in black, text 1. The presenter’s name is set in Segoe UI, 24 pt. The presenter’s job title, 18 point Segoe UI italic. Adjust font size and position on all text as needed.
GRAPHICS NOTE: This is a final slide to be used at your discretion or preference. No text should be on this page.